From: Integrated analysis of microRNA-target interactions with clinical outcomes for cancers
miRNA | Gene | p-value (HL:LH) | Gene Description |
---|---|---|---|
hsa-miR-124-3p | PACSIN3 | 4.02E-05 | Protein Kinase C And Casein Kinase Substrate In Neurons Protein |
hsa-miR-124-3p | SLC43A3 | 5.19E-05 | Solute carrier family 43, member 3 |
hsa-miR-148b-3p | EYA4 | 5.45E-05 | Eyes Absent (Drosophila) Homolog 4 |
hsa-miR-148a-3p | GAS1 | 7.66E-05 | Growth arrest-specific 1 |
hsa-miR-374b-5p | TAF7 | 1.38E-04 | TAF7 RNA Polymerase II, TATA Box Binding Protein (TBP)-Associated Factor |
hsa-miR-124-3p | SDF2L1 | 1.63E-04 | Stromal Cell Derived Factor 2 Like Protein 1 |
hsa-miR-98 | SLC35D2 | 1.83E-04 | Solute carrier family 35, member D2 |
hsa-miR-98 | PLAGL1* | 1.91E-04 | Pleomorphic adenoma gene-like 1 |
hsa-miR-124-3p | SERP1 | 2.09E-04 | Stress-associated endoplasmic reticulum protein 1 |
hsa-miR-196a-5p | LGR4 | 3.36E-04 | Leucine-Rich Repeat Containing G Protein-Coupled Receptor 4 |
hsa-miR-148b-3p | APBB2 | 3.86E-04 | Amyloid beta (A4) precursor protein-binding, family B, member 2 |
hsa-miR-98 | FNDC3A | 3.90E-04 | Fibronectin type III domain containing 3A |
hsa-miR-98 | MTUS1* | 4.03E-04 | Microtubule associated tumor suppressor 1 |
hsa-miR-98 | CDKAL1 | 4.47E-04 | CDK5 regulatory subunit associated protein 1-like 1 |
hsa-miR-98 | ZBED4 | 4.59E-04 | Zinc finger, BED-type containing 4 |
hsa-miR-124-3p | FCHSD2 | 5.28E-04 | FCH and double SH3 domains 2 |
hsa-miR-98 | UST | 5.69E-04 | Uronyl-2-Sulfotransferase |
hsa-miR-124-3p | ELF4* | 6.22E-04 | E74-Like Factor 4 (Ets Domain Transcription Factor) |
hsa-miR-98 | GNA12 | 6.52E-04 | Guanine Nucleotide Binding Protein (G Protein) Alpha 12 |
hsa-miR-98 | IFNGR1* | 6.69E-04 | Interferon gamma receptor 1 |